Get the Stockscreener App
5.16
7.86%
-0.44
After Hours:
5.25
0.09
+1.74%
Avita Medical Inc stock is traded at $5.16, with a volume of 220.64K.
It is down -7.86% in the last 24 hours and up +17.27% over the past month.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$5.60
Open:
$5.57
24h Volume:
220.64K
Relative Volume:
0.95
Market Cap:
$158.06M
Revenue:
$71.61M
Net Income/Loss:
$-48.59M
P/E Ratio:
-2.9469
EPS:
-1.751
Net Cash Flow:
$-32.88M
1W Performance:
+25.85%
1M Performance:
+17.27%
6M Performance:
-3.19%
1Y Performance:
-44.10%
1-Day Range:
$5.101
$5.65
1-Week Range:
$4.10
$5.85
52-Week Range:
$3.22
$10.29
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
5.16 | 171.54M | 71.61M | -48.59M | -32.88M | -1.751 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-05-26 | Initiated | Northland Capital | Outperform |
| Nov-20-25 | Upgrade | BTIG Research | Sell → Neutral |
| Aug-08-25 | Downgrade | BTIG Research | Neutral → Sell |
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
AVITA Medical wins BARDA contract worth up to $25.5M - MSN
AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association - Investing News Network
The pioneer behind spray-on skin wins burn care’s top honor - Stock Titan
Avita Medical (RCEL) Soars 14.1%: Is Further Upside Left in the Stock? - Yahoo Finance
Avita Medical (RCEL) Achieves Key Milestone in Skin Grafting Stu - GuruFocus
AVITA Medical Reports Accelerating Grafting Times in Positive Interim Results for Cohealyx-I Study - smallcaps.com.au
AVITA Medical up on Cohealyx data on grafting (RCEL:NASDAQ) - Seeking Alpha
AVITA Medical Announces Positive Interim Results from Cohealyx® Study - National Today
AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting - Investing News Network
Skin grafts in 11 days: AVITA posts interim Cohealyx wound data - Stock Titan
AVITA Medical Announces Positive Interim Results from Cohealyx Study Demonstrating Accelerated Time to Skin Grafting - Bitget
AVITA Medical, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Why this ASX healthcare stock is surging while the market sinks on Middle East fears - MSN
RCEL Technical Analysis & Stock Price Forecast - Intellectia AI
[EFFECT] AVITA Medical, Inc. SEC Filing - Stock Titan
AVITA Medical (RCEL) Secures $25.5M BARDA Deal for RECELL Deployment - GuruFocus
AVITA Medical: Why The BARDA Rally Changes Nothing (NASDAQ:RCEL) - Seeking Alpha
AVITA Medical stock gains on BARDA contract (RCEL:NASDAQ) - Seeking Alpha
Avita Medical (RCEL) Secures 10-Year Agreement with BARDA for Bu - GuruFocus
AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness - Investing News Network
AVITA Medical (AVHHL) asks shareholders to OK $900K director fee pool, 650K warrants - Stock Titan
AVITA Medical secures $25.5M BARDA burn preparedness contract By Investing.com - Investing.com UK
AVITA wins U.S. burn response deal covering 3,000 emergency units - Stock Titan
Chipmakers Recap: How cyclical is AVITA Medical Incs revenue streamQuarterly Risk Review & Fast Entry and Exit Trade Plans - baoquankhu1.vn
RCEL: Analyst Maintains Buy Rating, Target Price at $10.00 | RCE - GuruFocus
Avita Medical (NASDAQ:RCEL) Given Buy Rating at D. Boral Capital - MarketBeat
RCEL Stock Price, Quote & Chart | AVITA MEDICAL INC (NASDAQ:RCEL) - ChartMill
AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data - Investing News Network
Aug Fed Impact: Is AVITA Medical Inc stock forming a triangle patternQuarterly Portfolio Report & High Return Trade Guides - baoquankhu1.vn
RCEL PE Ratio & Valuation, Is RCEL Overvalued - Intellectia AI
A burn treatment cut hospital stays 36% as AVITA lines up 19 ABA talks - Stock Titan
AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2025 earnings call transcript - MSN
RCEL Should I Buy - Intellectia AI
AVITA Medical Inc (51KB.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Q2 2025 AVITA Medical Inc Earnings Call Transcript - GuruFocus
AVITA Medical Inc at TD Cowen Healthcare Conference Transcript - gurufocus.com
Avita Medical Files Shelf Registration Statement With US SEC; Shares Up 3% - 富途牛牛
AVITA Medical (RCEL) files $200M S-3 shelf to sell stock, warrants - Stock Titan
Quarterly Risk: Is AVITA Medical Inc stock suitable for long term investing2026 Buyback Activity & Daily Volume Surge Signals - baoquankhu1.vn
Momentum Shift: Is AVITA Medical Inc stock a good dividend stockWeekly Volume Report & Weekly Top Performers Watchlists - baoquankhu1.vn
AVITA Medical (RCEL) Price Target Decreased by 14.77% to 7.65 - MSN
RCEL Stock Decline Viewed as a Buying Opportunity by Analysts - GuruFocus
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avita Medical Inc Stock (RCEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McNamara Robert | Director |
Aug 28 '25 |
Buy |
4.50 |
10,000 |
45,000 |
86,771 |
| O'Toole David D | CFO |
Aug 26 '25 |
Buy |
4.52 |
2,000 |
9,040 |
31,657 |
| McNamara Robert | Director |
Aug 19 '25 |
Buy |
5.00 |
10,000 |
50,000 |
76,771 |
| O'Toole David D | CFO |
Aug 12 '25 |
Buy |
4.81 |
2,000 |
9,620 |
29,657 |
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):